Control of proteinuria with increased doses of agalsidase alfa in a patient with Fabry disease with atypical genotype–phenotype expression

Autor: Christos Paliouras, Georgios Aperis, Foteini Lamprianou, Giorgos Ntetskas, Konstantinos Roufas, Polichronis Alivanis
Jazyk: Spanish; Castilian
Rok vydání: 2015
Předmět:
Zdroj: Nefrología, Vol 35, Iss 6, Pp 578-581 (2015)
Druh dokumentu: article
ISSN: 0211-6995
DOI: 10.1016/j.nefro.2015.08.001
Popis: Fabry disease is a rare X-linked lysosomal storage disorder of glycosphingolipids, caused by the partial or complete deficiency of the lysosomal enzyme alpha-galactosidase A (a-Gal A). The missense mutation pN215S usually causes a milder form of the disease with isolated cardiac involvement. We report a case of a male Fabry patient with the pN215S mutation and a generalized disease. He suffered a relapse in proteinuria which responded to increased doses of the administered recombinant enzyme. Individualization of enzyme replacement therapy must be considered in selected cases characterized by clinical deterioration.
Databáze: Directory of Open Access Journals